Page last updated: 2024-10-31

mitoxantrone and Cirrhosis, Liver

mitoxantrone has been researched along with Cirrhosis, Liver in 2 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Research Excerpts

ExcerptRelevanceReference
"The overlap between hepatocellular carcinoma and cirrhosis, however, was such as to severely limit any value of the enzyme as a diagnostic test."1.28Serum and tissue alpha-L-fucosidase activity in the pre-clinical and clinical stages of hepatocellular carcinoma. ( Du, MQ; Hutchinson, WL; Johnson, PJ; Williams, R, 1991)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, M1
Liu, J1
Liu, L1
Yu, L1
Shi, B1
Ye, L1
Zhang, Y1
Chen, H1
Hutchinson, WL1
Johnson, PJ1
Du, MQ1
Williams, R1

Other Studies

2 other studies available for mitoxantrone and Cirrhosis, Liver

ArticleYear
A case report of acute myeloid leukemia after liver transplantation.
    Acta haematologica, 2013, Volume: 129, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Bone Marrow; Cytarabin

2013
Serum and tissue alpha-L-fucosidase activity in the pre-clinical and clinical stages of hepatocellular carcinoma.
    Clinical science (London, England : 1979), 1991, Volume: 81, Issue:2

    Topics: Adult; Aged; alpha-Fetoproteins; alpha-L-Fucosidase; Carcinoma, Hepatocellular; Doxorubicin; Female;

1991